J. Goldman & CO LP Bristol Myers Squibb CO Call Options Transaction History

J. Goldman & CO LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $4.03 Million - $5.3 Million	100,000 New	100,000 $4.15 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $1.82 Million - $2 Million	25,000 New	25,000 $1.93 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $7.8 Million - $11.3 Million	-168,037 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $8.27 Million - $10.8 Million	168,037 New	168,037 $18.2 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $18.3 Million - $21 Million	-305,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $18.3 Million - $19.9 Million	305,000	305,000 $18.7 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.